News & Press

Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value. SAN FRANCISCO & NEW YORK--(BUSINESS...

Nov 18, 2022

Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 -  Viz.ai, the leader in...

Nov 16, 2022

Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients. SAN FRANCISCO – November 15,...

Nov 15, 2022

Median size of aneurysms was 5mm, suggesting that AI-powered detection of incidental cerebral aneurysms can improve patient care pathways. SAN...

Nov 10, 2022

Comprehensive solution tailored for cardiovascular care teams to improve care pathways and grow referrals CHICAGO & SAN FRANCISCO--(BUSINESS WIRE)--AMERICAN HEART...

Nov 04, 2022

Partnership delivers critical insights to cardiac care teams for faster patient triage and care. SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in...

Nov 02, 2022

AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients...

Oct 31, 2022

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has named life sciences veteran Jieun Choe as chief...

Oct 25, 2022

Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity. SAN FRANCISCO – September...

Sep 01, 2022

AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care SAN FRANCISCO - July 27, 2022...

Jul 27, 2022

Viz.ai announced today it is partnering with Hyperfine, Inc., creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device,...

Jul 26, 2022

Round will fuel global expansion of AI-driven healthcare platform that accelerates access to life saving treatments SAN FRANCISCO – April...

Apr 07, 2022